Condition
Pseudohypoaldosteronism
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT00368446Completed
Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease
NCT06905600RecruitingPrimary
Transient Pseudohypoaldosteronism Affecting Children With Urinary Tract Malformation
NCT00323167Completed
Rare Genetic Disorders of the Breathing Airways
NCT00004328Phase 2CompletedPrimary
Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type I
Showing all 4 trials